Skip to main content
Second Regular Session | 75th General Assembly
Colorado General Assembly

PUBLIC
BILL SUMMARY For SB26-031

SENATE COMMITTEE ON HEALTH & HUMAN SERVICES
Date Feb 4, 2026       Location Old Supreme Court

SB26-031 - Lay Over
11:40:56 AM  
Senators Michaelson Jenet and Rich, primary bill sponsors, presented Senate Bill 26-031, which exempts controlled substances from being a schedule 1 substance under Colorado’s Uniform Control Substance Act if the substance is included in a prescription drug product approved for prescription use by the federal Food and Drug Administration, and designated or rescheduled by the Federal Drug Enforcement Administration (DEA). Any product containing the exempted substance must be controlled in the same manner as the DEA and any rescheduling of a prescription drug product is automatic and immediate upon the DEA’s rescheduling.

A handout was provided to the committee (Attachment A).
11:43:15 AM  
Mr. Luke Schartiger, representing themself, testified in support of the bill. Gretchen Shaub, representing Definium Therapeutics, testified in support of the bill. Rick Jarecke, representing Definium Therapeutics, testified in support of the bill. Dr. Andrew Novick, representing themself, testified in support of the bill.
11:56:10 AM  
The primary bill sponsors provided closing remarks, and asked that the bill be laid over for action only.